Treatment Responses Alter Myeloid Activation in BRAF-Mutant Melanoma 2252856
This work establishes for the first time that BRAFi promotes myeloid-mediated induction of T cell activation, which is lost at resistance but can be rescued with the addition of CDDO- me, and provides the foundation for its potential use in combination therapies for melanoma.